Results 241 to 250 of about 2,439,563 (414)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Spectrum of Biliary and Nonbiliary Neoplasms Growing and Spreading Within the Lumen of the Bile Ducts. [PDF]

Cancers (Basel)
Nakanuma Y, Sato Y, Kakuda Y, Oishi T.
europepmc   +1 more source

Chemically contaminated aquatic food resources and human cancer risk: retrospective [PDF]

, 1991
Dawe, C. J., Farrington, J. W., Fouts, J. R., Harshbarger, J. C., Murchelano, R. A., Ozonoff, D., Pritchard, J. B., Stegeman, J. J.   +7 more
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Pancreatic tail solid pseudopapillary neoplasm mimicking mucinous cystic neoplasm: case report and literature review. [PDF]

Int J Surg Case Rep
Machibya M, Mulokozi A, Ismail A, Mahmoud A, Ngimba C, Mwanga A.   +5 more
europepmc   +1 more source

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

New England Journal of Medicine, 1996
C. Hennekens, J. Buring, J. Manson, M. Stampfer, B. Rosner, N. Cook, C. Belanger, F. LaMotte, J. Gaziano, P. Ridker, W. Willett, R. Peto   +11 more
semanticscholar   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Pancreatic cystic neoplasms – clinical, radiological and pathological findings

, 2019
Marta Costa
openalex   +1 more source

Hepatobiliary and Pancreatic: Intraductal papillary mucinous neoplasm rupture: A rare cause of pancreatic fistula [PDF]

, 2019
Tsuyoshi Suda, Yukihiro Shirota, Yuji Hodo, Tokio Wakabayashi   +3 more
openalex   +1 more source

THYMIC NEOPLASMS

Journal of Thoracic Surgery, 1956
D B, EFFLER, L J, MCCORMACK
openaire   +2 more sources